Group 1 - The core viewpoint is that AI in healthcare is reshaping the industry ecosystem through applications like "Ant AiFu," which transforms top expert resources into 24/7 online services, achieving a digital closed loop of "medicine + drugs + insurance" and significantly reducing transaction costs across different segments [1] - Future investments in the pharmaceutical sector should focus on clinical value, with particular attention to innovative drugs and medical devices, as the valuation of the pharmaceutical sector is expected to recover under the resonance of policies and industry [1] - The domestic and international macro environment is improving, with healthcare insurance policies supporting the development of innovative drugs, enhancing the international competitiveness of the pharmaceutical industry, and likely increasing industry prosperity [1] Group 2 - The Medical ETF (159828) tracks the CSI Medical Index (399989), which selects listed companies in the fields of medical devices, medical services, and medical information technology from the Shanghai and Shenzhen markets to reflect the overall performance of securities related to the medical theme [1] - The CSI Medical Index focuses on the healthcare industry, exhibiting high growth potential and concentration, with a style leaning towards large-cap growth [1]
医疗ETF（159828）涨超1.1%，连续3日资金净流入，AI医疗应用或成行业新动能
Sou Hu Cai Jing·2025-12-25 06:58